Dihydroergocryptine

DB13385

small molecule experimental

Deskripsi

Struktur Molekul 2D

Struktur tidak tersedia

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

1057 Data
Phenytoin The metabolism of Dihydroergocryptine can be increased when combined with Phenytoin.
Fosphenytoin The metabolism of Dihydroergocryptine can be increased when combined with Fosphenytoin.
Valsartan Dihydroergocryptine may decrease the antihypertensive activities of Valsartan.
Ramipril Dihydroergocryptine may decrease the antihypertensive activities of Ramipril.
Reserpine Dihydroergocryptine may decrease the antihypertensive activities of Reserpine.
Remikiren Dihydroergocryptine may decrease the antihypertensive activities of Remikiren.
Torasemide Dihydroergocryptine may decrease the antihypertensive activities of Torasemide.
Guanadrel Dihydroergocryptine may decrease the antihypertensive activities of Guanadrel.
Olmesartan Dihydroergocryptine may decrease the antihypertensive activities of Olmesartan.
Chlorthalidone Dihydroergocryptine may decrease the antihypertensive activities of Chlorthalidone.
Nitroprusside Dihydroergocryptine may decrease the antihypertensive activities of Nitroprusside.
Minoxidil Dihydroergocryptine may decrease the antihypertensive activities of Minoxidil.
Treprostinil Dihydroergocryptine may decrease the antihypertensive activities of Treprostinil.
Bendroflumethiazide Dihydroergocryptine may decrease the antihypertensive activities of Bendroflumethiazide.
Prazosin Dihydroergocryptine may decrease the antihypertensive activities of Prazosin.
Fosinopril Dihydroergocryptine may decrease the antihypertensive activities of Fosinopril.
Trandolapril Dihydroergocryptine may decrease the antihypertensive activities of Trandolapril.
Metolazone Dihydroergocryptine may decrease the antihypertensive activities of Metolazone.
Benazepril Dihydroergocryptine may decrease the antihypertensive activities of Benazepril.
Cyclothiazide Dihydroergocryptine may decrease the antihypertensive activities of Cyclothiazide.
Candoxatril Dihydroergocryptine may decrease the antihypertensive activities of Candoxatril.
Mecamylamine Dihydroergocryptine may decrease the antihypertensive activities of Mecamylamine.
Moexipril Dihydroergocryptine may decrease the antihypertensive activities of Moexipril.
Lisinopril Dihydroergocryptine may decrease the antihypertensive activities of Lisinopril.
Metyrosine Dihydroergocryptine may decrease the antihypertensive activities of Metyrosine.
Hydroflumethiazide Dihydroergocryptine may decrease the antihypertensive activities of Hydroflumethiazide.
Cryptenamine Dihydroergocryptine may decrease the antihypertensive activities of Cryptenamine.
Perindopril Dihydroergocryptine may decrease the antihypertensive activities of Perindopril.
Candesartan cilexetil Dihydroergocryptine may decrease the antihypertensive activities of Candesartan cilexetil.
Eprosartan Dihydroergocryptine may decrease the antihypertensive activities of Eprosartan.
Chlorothiazide Dihydroergocryptine may decrease the antihypertensive activities of Chlorothiazide.
Quinapril Dihydroergocryptine may decrease the antihypertensive activities of Quinapril.
Telmisartan Dihydroergocryptine may decrease the antihypertensive activities of Telmisartan.
Hydrochlorothiazide Dihydroergocryptine may decrease the antihypertensive activities of Hydrochlorothiazide.
Trichlormethiazide Dihydroergocryptine may decrease the antihypertensive activities of Trichlormethiazide.
Deserpidine Dihydroergocryptine may decrease the antihypertensive activities of Deserpidine.
Pentolinium Dihydroergocryptine may decrease the antihypertensive activities of Pentolinium.
Trimethaphan Dihydroergocryptine may decrease the antihypertensive activities of Trimethaphan.
Diazoxide Dihydroergocryptine may decrease the antihypertensive activities of Diazoxide.
Bretylium Dihydroergocryptine may decrease the antihypertensive activities of Bretylium.
Terazosin Dihydroergocryptine may decrease the antihypertensive activities of Terazosin.
Captopril Dihydroergocryptine may decrease the antihypertensive activities of Captopril.
Epoprostenol Dihydroergocryptine may decrease the antihypertensive activities of Epoprostenol.
Polythiazide Dihydroergocryptine may decrease the antihypertensive activities of Polythiazide.
Cilazapril Dihydroergocryptine may decrease the antihypertensive activities of Cilazapril.
Saprisartan Dihydroergocryptine may decrease the antihypertensive activities of Saprisartan.
Spirapril Dihydroergocryptine may decrease the antihypertensive activities of Spirapril.
Tienilic acid Dihydroergocryptine may decrease the antihypertensive activities of Tienilic acid.
Debrisoquine Dihydroergocryptine may decrease the antihypertensive activities of Debrisoquine.
Diethylnorspermine Dihydroergocryptine may decrease the antihypertensive activities of Diethylnorspermine.
Temocapril Dihydroergocryptine may decrease the antihypertensive activities of Temocapril.
Hexamethonium Dihydroergocryptine may decrease the antihypertensive activities of Hexamethonium.
Trimazosin Dihydroergocryptine may decrease the antihypertensive activities of Trimazosin.
Nicorandil Dihydroergocryptine may decrease the antihypertensive activities of Nicorandil.
Rauwolfia serpentina root Dihydroergocryptine may decrease the antihypertensive activities of Rauwolfia serpentina root.
Enalaprilat Dihydroergocryptine may decrease the antihypertensive activities of Enalaprilat.
Angiotensin 1-7 Dihydroergocryptine may decrease the antihypertensive activities of Angiotensin 1-7.
Imidapril Dihydroergocryptine may decrease the antihypertensive activities of Imidapril.
BQ-123 Dihydroergocryptine may decrease the antihypertensive activities of BQ-123.
Cicletanine Dihydroergocryptine may decrease the antihypertensive activities of Cicletanine.
Dihydralazine Dihydroergocryptine may decrease the antihypertensive activities of Dihydralazine.
Zofenopril Dihydroergocryptine may decrease the antihypertensive activities of Zofenopril.
Guanoxan Dihydroergocryptine may decrease the antihypertensive activities of Guanoxan.
Delapril Dihydroergocryptine may decrease the antihypertensive activities of Delapril.
Vincamine Dihydroergocryptine may decrease the antihypertensive activities of Vincamine.
Linsidomine Dihydroergocryptine may decrease the antihypertensive activities of Linsidomine.
Guanoxabenz Dihydroergocryptine may decrease the antihypertensive activities of Guanoxabenz.
Tolonidine Dihydroergocryptine may decrease the antihypertensive activities of Tolonidine.
Endralazine Dihydroergocryptine may decrease the antihypertensive activities of Endralazine.
Cadralazine Dihydroergocryptine may decrease the antihypertensive activities of Cadralazine.
Cyclopenthiazide Dihydroergocryptine may decrease the antihypertensive activities of Cyclopenthiazide.
Bietaserpine Dihydroergocryptine may decrease the antihypertensive activities of Bietaserpine.
Guanazodine Dihydroergocryptine may decrease the antihypertensive activities of Guanazodine.
Methoserpidine Dihydroergocryptine may decrease the antihypertensive activities of Methoserpidine.
Guanoclor Dihydroergocryptine may decrease the antihypertensive activities of Guanoclor.
Muzolimine Dihydroergocryptine may decrease the antihypertensive activities of Muzolimine.
Xipamide Dihydroergocryptine may decrease the antihypertensive activities of Xipamide.
Candesartan Dihydroergocryptine may decrease the antihypertensive activities of Candesartan.
Tocopherylquinone Dihydroergocryptine may decrease the antihypertensive activities of Tocopherylquinone.
Benazeprilat Dihydroergocryptine may decrease the antihypertensive activities of Benazeprilat.
Fosinoprilat Dihydroergocryptine may decrease the antihypertensive activities of Fosinoprilat.
Ramiprilat Dihydroergocryptine may decrease the antihypertensive activities of Ramiprilat.
Perindoprilat Dihydroergocryptine may decrease the antihypertensive activities of Perindoprilat.
Quinaprilat Dihydroergocryptine may decrease the antihypertensive activities of Quinaprilat.
Furosemide Dihydroergocryptine may decrease the antihypertensive activities of Furosemide.
Enalapril Dihydroergocryptine may decrease the antihypertensive activities of Enalapril.
Amlodipine Dihydroergocryptine may decrease the antihypertensive activities of Amlodipine.
Nimodipine Dihydroergocryptine may decrease the antihypertensive activities of Nimodipine.
Lercanidipine Dihydroergocryptine may decrease the antihypertensive activities of Lercanidipine.
Indapamide Dihydroergocryptine may decrease the antihypertensive activities of Indapamide.
Nitrendipine Dihydroergocryptine may decrease the antihypertensive activities of Nitrendipine.
Guanethidine Dihydroergocryptine may decrease the antihypertensive activities of Guanethidine.
Bepridil Dihydroergocryptine may decrease the antihypertensive activities of Bepridil.
Ambrisentan Dihydroergocryptine may decrease the antihypertensive activities of Ambrisentan.
Pinacidil Dihydroergocryptine may decrease the antihypertensive activities of Pinacidil.
Riociguat Dihydroergocryptine may decrease the antihypertensive activities of Riociguat.
Macitentan Dihydroergocryptine may decrease the antihypertensive activities of Macitentan.
Aliskiren Dihydroergocryptine may decrease the antihypertensive activities of Aliskiren.
Lacidipine Dihydroergocryptine may decrease the antihypertensive activities of Lacidipine.
Niguldipine Dihydroergocryptine may decrease the antihypertensive activities of Niguldipine.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul